- $60.28m
- $197.83m
- $936.66m
- 25
- 76
- 53
- 50
Annual balance sheet for Neuehealth, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Net Total Receivables | — | — | 99.2 | 116 | 95.1 |
| Prepaid Expenses | |||||
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 39.2 | 83.7 | 42.6 | 14.5 | 11.2 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Insurance Receivables | |||||
| Other Long Term Assets | |||||
| Total Other Assets | |||||
| Total Assets | 1,811 | 3,598 | 4,665 | 1,225 | 544 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Policy Liabilities | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 633 | 2,453 | 3,945 | 1,569 | 979 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 1,177 | 1,145 | 720 | -344 | -435 |
| Total Liabilities & Shareholders' Equity | 1,811 | 3,598 | 4,665 | 1,225 | 544 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |